mucunguzi atukunda - Infectious Diseases

Author Information

Mucunguzi Atukunda is affiliated with the Infectious Diseases Research Collaboration in Kampala, Uganda. With a focus on infectious diseases, Atukunda's research prominently concerns public health challenges in rural East Africa, particularly in the domains of HIV, hypertension, and other chronic conditions.

Research Contributions

Mucunguzi Atukunda has made significant contributions to understanding the intersection of infectious and chronic diseases in rural East Africa. Key areas of research include the effectiveness of patient-centered strategies for hypertension management, the rapid initiation of antiretroviral therapy (ART), and the challenges and experiences associated with pre-exposure prophylaxis (PrEP) for HIV prevention. Atukunda has explored various public health interventions and their impact on populations at risk, particularly focusing on vulnerable groups such as pregnant women and young adults. Their work often involves community-based studies that provide valuable insights into health care delivery and epidemiology in resource-limited settings.

Aliases

No aliases were provided for Mucunguzi Atukunda.

Publication and Citation Metrics

Metric	Value
Total Papers	22
Citation Count	559
H-index	10

Publications:

Effect of a patient-centered hypertension delivery strategy on all-cause mortality: Secondary analysis of SEARCH, a community-randomized trial in rural Kenya and Uganda

DOI: 10.1371/journal.pmed.1003803

Year: 2021

Provider and Patient Perspectives of Rapid ART Initiation and Streamlined HIV Care: Qualitative Insights From Eastern African Communities

DOI: 10.1177/23259582211053518

Year: 2021

HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.

DOI: 10.1371/journal.pmed.1003492

Year: 2021

Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study

DOI: 10.1007/s10461-020-02780-x

Year: 2020

Population-level viral suppression among pregnant and postpartum women in a universal test and treat trial.

DOI: 10.1097/QAD.0000000000002564

Year: 2020

Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B

DOI: 10.1128/AAC.00838-20

Year: 2020

The age-specific burden and household and school-based predictors of child and adolescent tuberculosis infection in rural Uganda

DOI: 10.1371/journal.pone.0228102

Year: 2020

The epidemiology of chronic kidney disease (CKD) in rural East Africa: A population-based study

DOI: 10.1371/journal.pone.0229649

Year: 2020

Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study

DOI: 10.1016/S2352-3018(19)30433-3

Year: 2020

Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study

DOI: 10.1186/s12889-019-6838-6

Year: 2019

Why are Some Populations More Vulnerable?

How is Dengue Hemorrhagic Fever Transmitted?

How is HSV Transmitted?

What are the symptoms of Plasmodium falciparum malaria?

Why is the Apicoplast Important in Infectious Diseases?

When Should Stool Samples be Collected?

How Do They Monitor Disease Outbreaks?

How Do Insect Repellents Work?

What is Gonorrhea?

What Illnesses Do Adenoviruses Cause?

Partnered Content Networks

Relevant Topics